Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.53
-0.02 (-0.31%)
Last updated: Jan 21, 2026, 10:02 AM HKT

HKG:6922 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
85.1653.5340.9527.1522.439.05
Revenue Growth (YoY)
105.16%30.72%50.83%21.06%147.69%-
Cost of Revenue
27.7215.129.97.796.884.41
Gross Profit
57.4438.4131.0519.3615.554.64
Selling, General & Admin
101.6695.2874.788.3355.56126.9
Research & Development
54.1473.4676.1359.9338.8542.31
Operating Expenses
155.8168.74150.82148.2694.41169.21
Operating Income
-98.35-130.33-119.77-128.9-78.87-164.57
Interest Expense
-1.71-1.09-0.65-0.59-0.38-0.04
Interest & Investment Income
0.150.231.221.192.981.29
Currency Exchange Gain (Loss)
0.331.161.72.62--0.01
Other Non Operating Income (Expenses)
17.1818.8911.757.360.743.69
EBT Excluding Unusual Items
-82.41-111.14-105.75-118.32-75.52-159.64
Gain (Loss) on Sale of Investments
-----0.31
Other Unusual Items
-----50.97-
Pretax Income
-82.41-111.14-105.75-118.32-126.5-159.33
Income Tax Expense
0.140.13----
Earnings From Continuing Operations
-82.55-111.28-105.75-118.32-126.5-159.33
Minority Interest in Earnings
6.536.918.266.0924.6222.25
Net Income
-76.01-104.37-97.49-112.22-101.87-137.09
Net Income to Common
-76.01-104.37-97.49-112.22-101.87-137.09
Shares Outstanding (Basic)
239239239228228-
Shares Outstanding (Diluted)
239239239228228-
Shares Change (YoY)
--4.86%0.01%--
EPS (Basic)
-0.32-0.44-0.41-0.49-0.45-
EPS (Diluted)
-0.32-0.44-0.41-0.49-0.45-
Free Cash Flow
-39.88-84.79-111-103.95-74.93-35.71
Free Cash Flow Per Share
-0.17-0.35-0.46-0.46-0.33-
Gross Margin
67.45%71.75%75.83%71.32%69.32%51.25%
Operating Margin
-115.49%-243.46%-292.48%-474.77%-351.68%-1817.59%
Profit Margin
-89.25%-194.96%-238.06%-413.36%-454.26%-1514.08%
Free Cash Flow Margin
-46.82%-158.39%-271.05%-382.87%-334.11%-394.45%
EBITDA
-92.45-124.06-114.35-124.34-76.14-162.28
EBITDA Margin
-108.55%-231.76%-279.25%---
D&A For EBITDA
5.916.265.424.552.732.28
EBIT
-98.35-130.33-119.77-128.9-78.87-164.57
EBIT Margin
-115.49%-243.46%-292.48%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.